337 related articles for article (PubMed ID: 31808952)
1. The power and potential of integrated diagnostics in acute myeloid leukaemia.
Haferlach T; Schmidts I
Br J Haematol; 2020 Jan; 188(1):36-48. PubMed ID: 31808952
[TBL] [Abstract][Full Text] [Related]
2. [NGS-based molecular genetics of leukemia-a powerful and decentralized approach].
Dintner S; Schmutz M; Sommer S; Langer A; Hirschbühl K; Claus R; Schmid C; Trepel M; Märkl B
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):155-159. PubMed ID: 37975919
[TBL] [Abstract][Full Text] [Related]
3. Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia.
Haferlach T
Hematol Rep; 2020 Sep; 12(Suppl 1):8957. PubMed ID: 33042506
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics, classification and prognostic criteria of acute myeloid leukemia].
Heilmeier B; Buske C; Spiekermann K; Bohlander S; Feuring-Buske M; Hiddemann W; Braess J
Med Klin (Munich); 2007 Apr; 102(4):296-308. PubMed ID: 17426933
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostics of acute leukemias: interaction of phenotypic and genetic methods].
Bacher U; Haferlach C; Schnittger S; Kern W; Ott MM; Haferlach T
Pathologe; 2012 Nov; 33(6):528-38. PubMed ID: 23085696
[TBL] [Abstract][Full Text] [Related]
6. Case report: Concomitant Chronic Lymphocytic Leukaemia and Cytogenetically Normal de novo Acute Leukaemia in a Patient.
Kajtár B; Rajnics P; Egyed M; Alizadeh H
Ann Clin Lab Sci; 2015; 45(5):602-6. PubMed ID: 26586717
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.
Hur M; Chang YH; Lee DS; Park MH; Cho HI
Clin Lab Haematol; 2001 Jun; 23(3):173-9. PubMed ID: 11553058
[TBL] [Abstract][Full Text] [Related]
8. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
9. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
Rosli AA; Azlan A; Rajasegaran Y; Mot YY; Heidenreich O; Yusoff NM; Moses EJ
Clin Exp Med; 2023 Aug; 23(4):1137-1159. PubMed ID: 36229751
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
12. The rocky road to personalized medicine in acute myeloid leukaemia.
Brinda B; Khan I; Parkin B; Konig H
J Cell Mol Med; 2018 Mar; 22(3):1411-1427. PubMed ID: 29327808
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.
Lilljebjörn H; Orsmark-Pietras C; Mitelman F; Hagström-Andersson A; Fioretos T
Semin Cancer Biol; 2022 Sep; 84():40-49. PubMed ID: 34606984
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
George TI; Bajel A
Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine in AML: Function plus -omics is better than either alone.
Letai A
Cancer Cell; 2022 Aug; 40(8):804-806. PubMed ID: 35944499
[TBL] [Abstract][Full Text] [Related]
16. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review.
Stone M; Lilley CM; Tang G; Loghavi S; Mirza KM
Cytopathology; 2023 Nov; 34(6):530-541. PubMed ID: 37522274
[TBL] [Abstract][Full Text] [Related]
18. Minimal screening analysis based algorithm for diagnosis and clinical stratification of patients with acute myeloid leukaemia (AML): single centre experience.
Panovska-Stavridis I; Trajkova S; Ivanovski M; Hadzi-Pecova L; Dukovski D; Popova-Simjanovska M; Cevreska L
Prilozi; 2012; 33(1):93-106. PubMed ID: 22952097
[TBL] [Abstract][Full Text] [Related]
19. A study for evaluation of different diagnostic approaches in acute leukemia in Egypt.
Mahmoud LA; Shamaa SS; Salem MA; Aladle DA; Goda EF
Hematology; 2006 Apr; 11(2):87-95. PubMed ID: 16753847
[TBL] [Abstract][Full Text] [Related]
20. Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
Farina M; Rossi G; Bellotti D; Marchina E; Gale RP
Acta Haematol; 2016; 135(1):39-42. PubMed ID: 26376174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
